Amelioration of anemia after kidney transplantation in severe secondary oxalosis

Clinical Nephrology

Volumn 65, Issue 3, 2006, Pages 216-221

  Bernhardt, Wanja M ^a,b   Schefold, J C ^b   Weichert, W ^b   Rudolph, B ^b   Frei, U ^b   Groneberg, D A ^b   Schindler, R ^b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Bone marrow; Calcium oxalate; EPO resistance; Oxalobacter; Short bowel syndrome

Indexed keywords

ALPHA TOCOPHEROL; BICARBONATE; CALCIUM CARBONATE; CLOPIDOGREL; CYANOCOBALAMIN; ERYTHROPOIETIN; FUROSEMIDE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OXALIC ACID; PANCREAS ENZYME; PREDNISONE; PYRIDOXINE; RAPAMYCIN; SPIRONOLACTONE; THIAMINE; TSUKUBAENOLIDE; XIPAMIDE;

ADULT; ANEMIA; ARTICLE; CASE REPORT; CROHN DISEASE; FOLLOW UP; HEMATOCRIT; HEMODIAFILTRATION; HEMODIALYSIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTESTINE RESECTION; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; OXALOSIS; SHORT BOWEL SYNDROME; SMALL INTESTINE PERFORATION; THERAPY RESISTANCE; VASCULAR ACCESS;

EID: 33644765712     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CNP65216     Document Type: Article

References (25)

1. Alkhunaizi AM, Chan L 1996 Secondary oxalosis: a cause of delayed recovery of renal function in the setting of acute renal failure. J Am Soc Nephrol 7: 2320-2326
2. Balcke P, Schmidt P, Zazgornik J, Kopsa H, Deutsch E 1980 Secondary oxalosis in chronic renal insufficiency. N Engl J Med 303: 944
3. Balcke P, Schmidt P, Zazgornik J, Kopsa H, Haubenstock A 1984 Ascorbic acid aggravates secondary hyperoxaemia in patients on chronic hemodialysis. Ann Intern Med 101: 344-345
4. Broyer M, Jouvet P, Niaudet P, Daudon M, Revillon Y 1996 Management of oxalosis. Kidney Int Suppl 53: S93-S98
5. Campieri C, Campieri M, Bertuzzi V, Swennen E, Matteuzzi D, Stefoni S, Pirovano F, Centi C, Ulisse S, Famularo G, De Simone C 2001 Reduction of oxaluria after an oral course of lactic acid bacteria at high concentration. Kidney Int 60: 1097-105
6. Cuvelier C, Goffin E, Cosyns JP, Wauthier M, de Strihou CY 2002 Enteric hyperoxaluria: a hidden cause of early renal graft failure in two successive transplants: spontaneous late graft recovery. Am J Kidney Dis 40: E3
7. Danpure CJ 1991 Molecular and clinical heterogeneity in primary hyperoxaluria type 1. Am J Kidney Dis 17: 366-369
8. Das S, Joseph B, Dick AL 1979 Renal failure owing to oxalate nephrosis after jejunoileal bypass. J Urol 121: 506-509
9. Earnest DL, Johnson G, Williams HE, Admirand WH 1974 Hyperoxaluria in patients with ileal resection: an abnormality in dietary oxalate absorption. Gastroenterology 66: 1114-1122
10. Halbrooks PJ, Mason AB, Adams TE, Briggs SK, Everse SJ 2004 The oxalate effect on release of iron from human serum transferrin explained. J Mol Biol 339: 217-226
11. Hricik DE, Hussain R 1984 Pancytopenia and hepatosplenomegaly in oxalosis. Arch Intern Med 144: 167-168
12. Kistler H, Peter J, Thiel G, Brunner FP 1995 Seven-year survival of renal transplant for oxalate nephropathy due to short-bowel syndrome. Nephrol Dial Transplant 10: 1466-1469
13. Lieske JC, Walsh-Reitz MM, Toback FG 1992 Calcium oxalate monohydrate crystals are endocytosed by renal epithelial cells and induce proliferation. Am J Physiol 262: F622-F630
14. Lindsjo M, Fellstrom B, Ljunghall S, Wikstrom B, Danielson BG 1989 Treatment of enteric hyperoxaluria with calcium-containing organic marine hydrocolloid. Lancet 2: 701-704
15. Mandell I, Krauss E, Millan JC 1980 Oxalate-induced acute renal failure in Crohn's disease. Am J Med 69: 628-632
16. Roberts RA, Sketris IS, MacDonald AS, Belitsky P 1988 Renal transplantation in secondary oxalosis. Transplantation 45: 985-986
17. Sahin G, Acikalin MF, Yalcin AU 2005 Erythropoietin resistance as a result of oxalosis in bone marrow. Clin Nephrol 63: 402-404
18. Saunders DR, Sillery J, McDonald GB 1975 Regional differences in oxalate absorption by rat intestine: evidence for excessive absorption by the colon in steatorrhea. Gut 16: 543-548
19. Sidhu H, Schmidt ME, Cornelius JG, Thamilselvan S, Khan SR, Hesse A, Peck AB 1999 Direct correlation between hyperoxaluria/oxalate stone disease and the absence of the gastrointestinal tract-dwelling bacterium Oxalobacter formigenes: possible prevention by gut recolonization or enzyme replacement therapy. J Am Soc Nephrol 10 (Suppl 14): S334-S340
20. Smith LH, Fromm H, Hofmann AF 1972 Acquired hyperoxaluria, nephrolithiasis and intestinal disease. Description of a syndrome. N Engl J Med 286: 1371-1375
21. Sud K, Swaminathan S, Varma N, Kohli HS Jha V, Gupta KL, Sakhuja V 2004 Reversal of pancytopenia following kidney transplantation in a patient of primary hyperoxaluria with bone marrow involvement. Nephrology (Carlton) 9: 422-425
22. Sullivan JF, Eisenstein AB 1970 Ascorbic acid depletion in patients undergoing chronic hemodialysis. Am J Clin Nutr 23: 1339-1346
23. Walter MJ, Dang CV 1998 Pancytopenia secondary to oxalosis in a 23-year-old woman. Blood 91: 4394
24. Webster KE, Cramer SD 2000 Genetic basis of primary hyperoxaluria type II. Mol Urol 4: 355-364
25. Weinman EJ, Frankfurt SJ, Ince A, Sansom S 1978 Renal tubular transport of organic acids. Studies with oxalate and para-aminohippurate in the rat. J Clin Invest 61: 801-806